Takara Common Stock from 2010 to 2026

TF2 Stock  EUR 6.10  0.25  4.27%   
Takara Bio's Common Stock is decreasing over the last several years with slightly volatile swings. Common Stock is predicted to flatten to about 12 B. During the period from 2010 to 2026 Takara Bio Common Stock regressed destribution of quarterly values had coefficient of variationof  5.38 and r-value of (0.54). View All Fundamentals
 
Common Stock  
First Reported
2016-12-31
Previous Quarter
15 B
Current Value
15 B
Quarterly Volatility
0.0
 
Covid
 
Interest Hikes
Check Takara Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Takara Bio's main balance sheet or income statement drivers, such as Interest Expense of 24.1 M, Selling General Administrative of 601.1 M or Total Revenue of 45.1 B, as well as many indicators such as . Takara financial statements analysis is a perfect complement when working with Takara Bio Valuation or Volatility modules.
  
This module can also supplement various Takara Bio Technical models . Check out the analysis of Takara Bio Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Takara Stock

Takara Bio financial ratios help investors to determine whether Takara Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Takara with respect to the benefits of owning Takara Bio security.